Market Entry Intelligence
Structured market entry framework that reduced due diligence cycles and supported a first-close raise within the target window.
The challenge
Launch readiness blocked by the gap between clinical conviction and investor-grade commercial intelligence.
The founding team had a clear clinical vision and a target geography, but no structured approach to translating that into investor-ready market positioning. The competitive landscape was fragmented and poorly documented. Demand signals existed — social data, demographic trends, patient search behaviour — but sat in disconnected sources that hadn't been synthesised. Without a coherent view of market sizing, competitive whitespace, and realistic unit economics, the pitch deck was conceptually strong but analytically thin. Investors at series seed stage were increasingly asking for evidence of operational thinking, not just clinical differentiation.
The system
Decision system built
We built a structured market intelligence and financial modelling system that combined external demand signals, competitive landscape analysis, and bottom-up unit economics modelling into a coherent investment narrative. The system was designed to be updatable — not a one-time deck, but a living analytical layer the founding team could interrogate as assumptions changed.
System components
Demand signal aggregation: demographic data, search intent, social listening, and treatment category growth rates synthesised into a local addressable market estimate
Competitive mapping layer: tiered analysis of existing operators by location, service breadth, pricing signals, digital presence, and estimated capacity utilisation
Unit economics model: bottom-up revenue build from patient acquisition cost assumptions, visit frequency benchmarks, treatment mix, and EBITDA sensitivity to retention rate
Whitespace identification: gap analysis across treatment categories, price points, and patient demographics to identify underserved positioning
Investor narrative structuring: translation of quantitative findings into a defensible thesis with clearly stated assumptions and risk factors
How we worked
Engagement scope
Market intelligence, competitive landscape analysis, unit economics modelling, and investor narrative development for a pre-launch medical aesthetics operator.
Timeline
Six-week primary engagement with a structured handoff of the financial model and ongoing availability for investor Q&A support.
Operating model
Small advisory team embedded with the founding group. Weekly synthesis sessions to pressure-test assumptions. Final outputs designed for both investor consumption and internal operating use.
Outcomes
Business impact & measurable results
Structured market entry framework that reduced due diligence cycles and supported a first-close raise within the target window.
Investor-ready market entry pack delivered in 6 weeks, reducing the founding team's pre-raise preparation time by an estimated 60% versus a self-directed research approach
Unit economics model identified that retention rate at month 12 was the single most sensitive variable in achieving target EBITDA — this became the operational focus for the first year of trading
Competitive whitespace analysis surfaced a mid-market positioning gap that existing operators had not addressed, informing a pricing and service architecture that was meaningfully distinct from both the premium clinic tier and the corporate medspa model
First investor close achieved within the target window; lead investor cited the analytical rigour of market sizing and unit economics as a key confidence signal
Governance
Trust, collaboration & governance
All assumptions stated explicitly with source attribution — no black-box numbers presented to investors
Sensitivity analysis built into the unit economics model so the founding team could stress-test their own scenarios
Competitive intelligence gathered through primary and secondary methods, with clear flags on data confidence levels
Risk factors presented honestly including cannibalisation dynamics, supply-side constraints, and regulatory trajectory in the UK market
Reframe
Market entry intelligence shapes the plan — it doesn't layer on top of it.
Across every engagement, the goal is the same: engineer a system that makes better decisions — faster, more consistently, and at scale — than the process it replaces.
Start a discovery
Most engagements begin with a conversation about context.
We do not send a proposal before we understand the problem. Start by telling us about your decision context — we will identify the highest-leverage intervention areas before any scope is agreed.